HIV Diagnosis & Treatment Market, Global Outlook and Forecast 2022-2028

April 2022 | 65 pages | ID: HA6BDF08FC80EN
Market Monitor Global

Abstracts

HIV prevalence in Africa, specifically in Southern region is very high as compared to North African region. Approximately 1 out of 4 is suffering from HIV. Southern and Eastern region of Africa has one of the highest prevalence rate of HIV, about 19 million people have HIV. While HIV prevalence is low in North Africa but the number of cases of HIV are increasing rapidly. There is no cure for HIV but drugs manufacturing companies are investing huge money in R&D to develop drugs for HIV.

This report contains market size and forecasts of HIV Diagnosis & Treatment in Global, including the following market information:

Global HIV Diagnosis & Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global HIV Diagnosis & Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

ELISA Test Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of HIV Diagnosis & Treatment include Abbott Laboratories, Boehringer Ingelheim, Bristol-Myers Squibb, Cipla, F. Hoffmann-La Roche, Gilead, GlaxoSmithKline and Johnson & Johnson, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the HIV Diagnosis & Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global HIV Diagnosis & Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global HIV Diagnosis & Treatment Market Segment Percentages, by Type, 2021 (%)

• ELISA Test
• Saliva Tests
• Viral Load Test
• Western Blot
• Others

Global HIV Diagnosis & Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global HIV Diagnosis & Treatment Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Clinics

Global HIV Diagnosis & Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global HIV Diagnosis & Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies HIV Diagnosis & Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies HIV Diagnosis & Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Abbott Laboratories
• Boehringer Ingelheim
• Bristol-Myers Squibb
• Cipla
• F. Hoffmann-La Roche
• Gilead
• GlaxoSmithKline
• Johnson & Johnson

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 HIV Diagnosis & Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global HIV Diagnosis & Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL HIV DIAGNOSIS & TREATMENT OVERALL MARKET SIZE

2.1 Global HIV Diagnosis & Treatment Market Size: 2021 VS 2028
2.2 Global HIV Diagnosis & Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top HIV Diagnosis & Treatment Players in Global Market
3.2 Top Global HIV Diagnosis & Treatment Companies Ranked by Revenue
3.3 Global HIV Diagnosis & Treatment Revenue by Companies
3.4 Top 3 and Top 5 HIV Diagnosis & Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies HIV Diagnosis & Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 HIV Diagnosis & Treatment Players in Global Market
  3.6.1 List of Global Tier 1 HIV Diagnosis & Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 HIV Diagnosis & Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global HIV Diagnosis & Treatment Market Size Markets, 2021 & 2028
  4.1.2 ELISA Test
  4.1.3 Saliva Tests
  4.1.4 Viral Load Test
  4.1.5 Western Blot
  4.1.6 Others
4.2 By Type - Global HIV Diagnosis & Treatment Revenue & Forecasts
  4.2.1 By Type - Global HIV Diagnosis & Treatment Revenue, 2017-2022
  4.2.2 By Type - Global HIV Diagnosis & Treatment Revenue, 2023-2028
  4.2.3 By Type - Global HIV Diagnosis & Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global HIV Diagnosis & Treatment Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Clinics
5.2 By Application - Global HIV Diagnosis & Treatment Revenue & Forecasts
  5.2.1 By Application - Global HIV Diagnosis & Treatment Revenue, 2017-2022
  5.2.2 By Application - Global HIV Diagnosis & Treatment Revenue, 2023-2028
  5.2.3 By Application - Global HIV Diagnosis & Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global HIV Diagnosis & Treatment Market Size, 2021 & 2028
6.2 By Region - Global HIV Diagnosis & Treatment Revenue & Forecasts
  6.2.1 By Region - Global HIV Diagnosis & Treatment Revenue, 2017-2022
  6.2.2 By Region - Global HIV Diagnosis & Treatment Revenue, 2023-2028
  6.2.3 By Region - Global HIV Diagnosis & Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America HIV Diagnosis & Treatment Revenue, 2017-2028
  6.3.2 US HIV Diagnosis & Treatment Market Size, 2017-2028
  6.3.3 Canada HIV Diagnosis & Treatment Market Size, 2017-2028
  6.3.4 Mexico HIV Diagnosis & Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe HIV Diagnosis & Treatment Revenue, 2017-2028
  6.4.2 Germany HIV Diagnosis & Treatment Market Size, 2017-2028
  6.4.3 France HIV Diagnosis & Treatment Market Size, 2017-2028
  6.4.4 U.K. HIV Diagnosis & Treatment Market Size, 2017-2028
  6.4.5 Italy HIV Diagnosis & Treatment Market Size, 2017-2028
  6.4.6 Russia HIV Diagnosis & Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries HIV Diagnosis & Treatment Market Size, 2017-2028
  6.4.8 Benelux HIV Diagnosis & Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia HIV Diagnosis & Treatment Revenue, 2017-2028
  6.5.2 China HIV Diagnosis & Treatment Market Size, 2017-2028
  6.5.3 Japan HIV Diagnosis & Treatment Market Size, 2017-2028
  6.5.4 South Korea HIV Diagnosis & Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia HIV Diagnosis & Treatment Market Size, 2017-2028
  6.5.6 India HIV Diagnosis & Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America HIV Diagnosis & Treatment Revenue, 2017-2028
  6.6.2 Brazil HIV Diagnosis & Treatment Market Size, 2017-2028
  6.6.3 Argentina HIV Diagnosis & Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa HIV Diagnosis & Treatment Revenue, 2017-2028
  6.7.2 Turkey HIV Diagnosis & Treatment Market Size, 2017-2028
  6.7.3 Israel HIV Diagnosis & Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia HIV Diagnosis & Treatment Market Size, 2017-2028
  6.7.5 UAE HIV Diagnosis & Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Abbott Laboratories
  7.1.1 Abbott Laboratories Corporate Summary
  7.1.2 Abbott Laboratories Business Overview
  7.1.3 Abbott Laboratories HIV Diagnosis & Treatment Major Product Offerings
  7.1.4 Abbott Laboratories HIV Diagnosis & Treatment Revenue in Global Market (2017-2022)
  7.1.5 Abbott Laboratories Key News
7.2 Boehringer Ingelheim
  7.2.1 Boehringer Ingelheim Corporate Summary
  7.2.2 Boehringer Ingelheim Business Overview
  7.2.3 Boehringer Ingelheim HIV Diagnosis & Treatment Major Product Offerings
  7.2.4 Boehringer Ingelheim HIV Diagnosis & Treatment Revenue in Global Market (2017-2022)
  7.2.5 Boehringer Ingelheim Key News
7.3 Bristol-Myers Squibb
  7.3.1 Bristol-Myers Squibb Corporate Summary
  7.3.2 Bristol-Myers Squibb Business Overview
  7.3.3 Bristol-Myers Squibb HIV Diagnosis & Treatment Major Product Offerings
  7.3.4 Bristol-Myers Squibb HIV Diagnosis & Treatment Revenue in Global Market (2017-2022)
  7.3.5 Bristol-Myers Squibb Key News
7.4 Cipla
  7.4.1 Cipla Corporate Summary
  7.4.2 Cipla Business Overview
  7.4.3 Cipla HIV Diagnosis & Treatment Major Product Offerings
  7.4.4 Cipla HIV Diagnosis & Treatment Revenue in Global Market (2017-2022)
  7.4.5 Cipla Key News
7.5 F. Hoffmann-La Roche
  7.5.1 F. Hoffmann-La Roche Corporate Summary
  7.5.2 F. Hoffmann-La Roche Business Overview
  7.5.3 F. Hoffmann-La Roche HIV Diagnosis & Treatment Major Product Offerings
  7.5.4 F. Hoffmann-La Roche HIV Diagnosis & Treatment Revenue in Global Market (2017-2022)
  7.5.5 F. Hoffmann-La Roche Key News
7.6 Gilead
  7.6.1 Gilead Corporate Summary
  7.6.2 Gilead Business Overview
  7.6.3 Gilead HIV Diagnosis & Treatment Major Product Offerings
  7.6.4 Gilead HIV Diagnosis & Treatment Revenue in Global Market (2017-2022)
  7.6.5 Gilead Key News
7.7 GlaxoSmithKline
  7.7.1 GlaxoSmithKline Corporate Summary
  7.7.2 GlaxoSmithKline Business Overview
  7.7.3 GlaxoSmithKline HIV Diagnosis & Treatment Major Product Offerings
  7.7.4 GlaxoSmithKline HIV Diagnosis & Treatment Revenue in Global Market (2017-2022)
  7.7.5 GlaxoSmithKline Key News
7.8 Johnson & Johnson
  7.8.1 Johnson & Johnson Corporate Summary
  7.8.2 Johnson & Johnson Business Overview
  7.8.3 Johnson & Johnson HIV Diagnosis & Treatment Major Product Offerings
  7.8.4 Johnson & Johnson HIV Diagnosis & Treatment Revenue in Global Market (2017-2022)
  7.8.5 Johnson & Johnson Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. HIV Diagnosis & Treatment Market Opportunities & Trends in Global Market
Table 2. HIV Diagnosis & Treatment Market Drivers in Global Market
Table 3. HIV Diagnosis & Treatment Market Restraints in Global Market
Table 4. Key Players of HIV Diagnosis & Treatment in Global Market
Table 5. Top HIV Diagnosis & Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global HIV Diagnosis & Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global HIV Diagnosis & Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies HIV Diagnosis & Treatment Product Type
Table 9. List of Global Tier 1 HIV Diagnosis & Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 HIV Diagnosis & Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global HIV Diagnosis & Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - HIV Diagnosis & Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - HIV Diagnosis & Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global HIV Diagnosis & Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - HIV Diagnosis & Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - HIV Diagnosis & Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global HIV Diagnosis & Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global HIV Diagnosis & Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global HIV Diagnosis & Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America HIV Diagnosis & Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America HIV Diagnosis & Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe HIV Diagnosis & Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe HIV Diagnosis & Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia HIV Diagnosis & Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia HIV Diagnosis & Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America HIV Diagnosis & Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America HIV Diagnosis & Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa HIV Diagnosis & Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa HIV Diagnosis & Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Abbott Laboratories Corporate Summary
Table 31. Abbott Laboratories HIV Diagnosis & Treatment Product Offerings
Table 32. Abbott Laboratories HIV Diagnosis & Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Boehringer Ingelheim Corporate Summary
Table 34. Boehringer Ingelheim HIV Diagnosis & Treatment Product Offerings
Table 35. Boehringer Ingelheim HIV Diagnosis & Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Bristol-Myers Squibb Corporate Summary
Table 37. Bristol-Myers Squibb HIV Diagnosis & Treatment Product Offerings
Table 38. Bristol-Myers Squibb HIV Diagnosis & Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Cipla Corporate Summary
Table 40. Cipla HIV Diagnosis & Treatment Product Offerings
Table 41. Cipla HIV Diagnosis & Treatment Revenue (US$, Mn), (2017-2022)
Table 42. F. Hoffmann-La Roche Corporate Summary
Table 43. F. Hoffmann-La Roche HIV Diagnosis & Treatment Product Offerings
Table 44. F. Hoffmann-La Roche HIV Diagnosis & Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Gilead Corporate Summary
Table 46. Gilead HIV Diagnosis & Treatment Product Offerings
Table 47. Gilead HIV Diagnosis & Treatment Revenue (US$, Mn), (2017-2022)
Table 48. GlaxoSmithKline Corporate Summary
Table 49. GlaxoSmithKline HIV Diagnosis & Treatment Product Offerings
Table 50. GlaxoSmithKline HIV Diagnosis & Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Johnson & Johnson Corporate Summary
Table 52. Johnson & Johnson HIV Diagnosis & Treatment Product Offerings
Table 53. Johnson & Johnson HIV Diagnosis & Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. HIV Diagnosis & Treatment Segment by Type in 2021
Figure 2. HIV Diagnosis & Treatment Segment by Application in 2021
Figure 3. Global HIV Diagnosis & Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global HIV Diagnosis & Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global HIV Diagnosis & Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by HIV Diagnosis & Treatment Revenue in 2021
Figure 8. By Type - Global HIV Diagnosis & Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global HIV Diagnosis & Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global HIV Diagnosis & Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America HIV Diagnosis & Treatment Revenue Market Share, 2017-2028
Figure 12. US HIV Diagnosis & Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada HIV Diagnosis & Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico HIV Diagnosis & Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe HIV Diagnosis & Treatment Revenue Market Share, 2017-2028
Figure 16. Germany HIV Diagnosis & Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France HIV Diagnosis & Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. HIV Diagnosis & Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy HIV Diagnosis & Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia HIV Diagnosis & Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries HIV Diagnosis & Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux HIV Diagnosis & Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia HIV Diagnosis & Treatment Revenue Market Share, 2017-2028
Figure 24. China HIV Diagnosis & Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan HIV Diagnosis & Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea HIV Diagnosis & Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia HIV Diagnosis & Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India HIV Diagnosis & Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America HIV Diagnosis & Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil HIV Diagnosis & Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina HIV Diagnosis & Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa HIV Diagnosis & Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey HIV Diagnosis & Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel HIV Diagnosis & Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia HIV Diagnosis & Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE HIV Diagnosis & Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Abbott Laboratories HIV Diagnosis & Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Boehringer Ingelheim HIV Diagnosis & Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Bristol-Myers Squibb HIV Diagnosis & Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Cipla HIV Diagnosis & Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. F. Hoffmann-La Roche HIV Diagnosis & Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Gilead HIV Diagnosis & Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. GlaxoSmithKline HIV Diagnosis & Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Johnson & Johnson HIV Diagnosis & Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)